Hyderabad (Telangana) [India], October 09: Optimus Pharma Private Limited today announced that it has received tentative approval from the United States Food and Drug Administration (FDA) for the generic equivalent of Rexulti® Tablets, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, and 4 mg, of Otsuka Pharmaceutical Co., Ltd. Optimus Pharma’s approval for its Abbreviated New Drug Application (ANDA) BREXPIPRAZOLE Tablets, 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, and 4 mg, was received on October 8th, 2021. BREXPIPRAZOLE will be manufactured at Optimus Pharma’s Pashmylaram USFDA accredited facility in India.

BREXPIPRAZOLE Tablets (RLD: Rexulti® Tablets) had estimated annual sales of USD 1258 million in the U.S. (IQVIA MAT July 2021).

BREXPIPRAZOLE has a favourable antipsychotic profile in terms of improvement of cognitive performance and sleep patterns, as well as effects on affective states and potential to treat core symptoms in schizophrenia and major depressive disorder, including cognitive deficits with a low risk of adverse effects (extrapyramidal symptoms, metabolic complications, weight gain, akathisia potential) that are commonly encountered with other typical and second-generation antipsychotic drugs. From the studies done so far, it can be concluded that BREXPIPRAZOLE can be effective monotherapy for schizophrenia and as an adjunct to other antidepressant medications in major depressive disorder.

About Optimus Pharma

Optimus was established in the year 2004 as a custom synthesis laboratory by a team of techno-commercial experts. It is one of the fastest-growing Manufacturer in Active Pharmaceutical Ingredients (APIs) and Finished dosages. Over the last decade, we have been certified and audited by reputed Global Regulatory Agencies like USFDA, WHO, COFEPRIS, EMA, KFDA and AFM from PMDA Japan. Optimus Pharma is a vertically integrated pharmaceutical company engaged in the manufacturing of Solid Oral and semisolid formulations. We have successfully integrated our API and Formulation R&D teams, with the IP and Regulatory Affairs team in order to ensure a dynamic product portfolio. We help our customers serve global markets with technology based, innovative, cost effective & consumer friendly products of the highest quality.

46 Replies to “Optimus Receives Tentative Approval from U.S. FDA for Brexpiprazole Tablets”

  1. Pingback: wow slot
  2. Pingback: Esport
  3. Pingback: Seksin Katsominen
  4. Pingback: sbobet
  5. Pingback: sbo
  6. Pingback: sbo
  7. Pingback: แทงบอล
  8. Pingback: dmt toad for sale
  9. Pingback: view website
  10. Hello! This is my first comment here so I just wanted to
    give a quick shout out and say I really enjoy reading your
    blog posts. Can you suggest any other blogs/websites/forums that
    deal with the same subjects? Many thanks!

  11. What i don’t realize is in truth how you are not actually a
    lot more well-preferred than you might be now. You are very intelligent.
    You know thus significantly with regards to this matter,
    made me in my opinion imagine it from so many various angles.
    Its like women and men aren’t fascinated unless it is
    something to accomplish with Lady gaga! Your personal stuffs great.
    At all times care for it up!

  12. Pingback: Visit This Link
  13. I loved as much as you will receive carried out right here.
    The sketch is attractive, your authored subject matter stylish.
    nonetheless, you command get bought an shakiness over that
    you wish be delivering the following. unwell unquestionably come
    further formerly again as exactly the same nearly very often inside
    case you shield this increase.

  14. It’s a shame you don’t have a donate button! I’d
    certainly donate to this excellent blog! I suppose
    for now i’ll settle for book-marking and adding your RSS feed to my
    Google account. I look forward to brand new updates and will share this site
    with my Facebook group. Chat soon!

  15. Hey there, I think your website might be having browser compatibility issues.
    When I look at your blog in Chrome, it looks fine but when opening in Internet Explorer,
    it has some overlapping. I just wanted to give you a quick heads up!
    Other then that, great blog!

Leave a Reply

Your email address will not be published.